Synthesis,Crystal Structure and Biological Activity of 25,27-Di(α,γ-diketo-p-methylphenylbutoxy)-26,28-dihydroxy p-tert-butylcalix[4]arene

The title complex(C66H76O8·CH3CN) was synthesized and structurally determined by single-crystal X-ray diffraction method. It crystallizes in monoclinic, space group P21/c with a = 22.384(13), b = 13.413(7), c = 21.867(12), β = 112.257(7)°, C68H78NO8, Mr = 1037.31, Dc = 1.133 g/cm3, V = 6076(6) 3, Z = 4, F(000) = 2224, μ(MoKa) = 0.073 mm-1, T = 296(2) K, 10276 independent reflections with 5469 observed ones(I 2σ(I)), R = 0.0797 and wR = 0.2316 with GOF = 1.027(R = 0.1442 and wR = 0.2689 for all data). The calixarene moiety maintains the symmetric cone conformation through intramolecular O–H···O hydrogen bonds. The inhibition of the strand transfer process of HIV-1 integrase of the title compound was also evaluated. Preliminary bioassays indicated that it has a low inhibition ratio(24.85%) at the concentration of 50 μM.     

A Novel 3D Supramolecular Framework of Poly[(5-(oxidediphenylphosphino)isophthalate)zinc(Ⅱ)]: Syntheses and Structure

A novel metal-organic framework, namely [Zn(C20H13O5P)]n(1), has been hydrothermally synthesized through the reaction of 5-(oxidediphenylphosphino)isophthalic acid(H2L) with Zn(Ⅱ) salt. The title compound crystallizes in monoclinic, space group P21/c with a = 11.0966(10), b = 14.5651(14), c = 14.7311(15), β = 130.022(6)o, C20H13O5 PZn, Mr = 429.64, V = 1823.3(3) 3, Dc = 1.565 g/cm3, F(000) = 872, μ = 1.463 mm-1, S = 1.054 and Z = 4. The final R = 0.0270 and wR = 0.0739 for 2769 observed reflections with I 2σ(I). In the title complex, the Zn2(CO2)2 binuclear clusters are linked by L2- ligands to result in a pillared layer structure in the bc plane, which is a(4,4)-net composed of helical chains with opposite chirality by sharing Zn2(CO2)2 units. Adjacent layers are further associated together through Zn–O bonds involving the metal center and the oxygen atom of P=O group to achieve a 3D architecture, in which one-dimensional quadrangled channel displays the interweaving of two pairs of coaxial double-helical chains with opposite chirality. The luminescence property and thermogravimetric analysis of the title complex were investigated.     

Synthesis,Structure and Luminescent Property of a New bnn-type Zn(Ⅱ) Coordination Polymer

A new Zn(Ⅱ) coordination polymer, namely [Zn(Htci)(bib)0.5(H2O)]n·nH2O(1, H3 tci = tri(2-carboxyethyl)isocyanurate, bib = 1,4-bis(imidazol-1-ylmethyl)-butane) has been synthesized by combining H3 tci and bib ligands with Zn(Ⅱ) salts under solvothermal conditions. The title compound crystallizes in monoclinic, space group P21/c with a = 13.3424(7), b = 7.9051(5), c = 20.4650(12) , β = 101.935(5)o, V = 2111.8(2) 3, C17H24N5O11 Zn, Mr = 539.8, Z = 4, Dc = 1.698 g/cm3, F(000) = 1116, μ = 1.236 mm-1, the final R = 0.0398 and wR = 0.00879 for 3722 observed reflections(I 2■(I)). X-ray structural analysis reveals that compound 1 exhibits a three-dimensional(3D) pillar-layered framework, and can be simplified into a 5-connected bnn topological network. Moreover, the luminescent properties for compound 1 were also studied at room temperature.     

Hydrothermal Synthesis, Crystal Structure and Photoluminescence of [Sm（PCA）_3（H_2O）_2]_n·6nH_2O

A new one-dimensional (1-D) compound [Sm(PCA)3(H2O)2]n·6nH2O (1, HPCA=pyrazinecarboxylic acid) has been synthesized via hydrothermal reaction and structurally characterized by single-crystal X-ray diffraction. Compound 1 crystallizes in the Pbca space group of orthorhombic system with a=19.465(3), b=12.034(4), c=19.842(4) , V=4648(2)3, C15H25N6O14Sm, Mr=663.76, Dc=1.897 g/cm3, S=1.023, μ(MoKα)=2.610 mm-1, F(000)=2648, R=0.0239 and wR=0.0616. Compound 1 is characteristic of an infinite 1-D chain-like structure with the samarium atoms locating at an environment of a monocapped square antiprism. The [Sm(PCA)3(H2O)2]n chains and the lattice water molecules interconnect together through π-π interactions and hydrogen bonding interactions to yield a 3-D supramolecular framework. Photoluminescent investigation reveals that the title compound displays an emission in the greenish blue region.     

Synthesis,Bioactivity and Crystal Structure Analysis of Diisopropyl[（4-cyanopyrazol-3-ylamino）（2-hydroxyl-phenyl） methyl]phosphonate

The title compound,diisopropyl[(4-cyanopyrazol-3-ylamino)(2-hydroxylphenyl) -methyl] phosphonate was synthesized by the addition reaction of diisopropyl phosphite and N-(4-cyanopyrazole-3-yl) -2-hydroxylphenyl-imine. Its structure was characterized by IR,1H NMR,elemental analysis and single-crystal X-ray diffraction. The crystal belongs to the triclinic system,space group P1 with a = 9.1840(13) ,b = 9.2278(13),c = 12.1952(17) ,α = 93.846(2) ,β = 90.947(2) ,γ = 111.289(2) °,V = 959.9(3) 3,Dc = 1.309 g/cm3,Z = 2,μ(MoKa) = 0.173,F(000) = 400,the final R = 0.0414 and wR = 0.1196 for 2985 observed reflections(I > 2σ(I)) . The pyrazole and benzene moieties are approximately coplanar in each case. The dihedral angle between planes 1 and 2 is 82.99°. The crystal structure is stabilized by three intermolecular hydrogen bonds of O(1) -H(1) …O(2) ,N(2) -H(2) …N(3) and N(2) -H(2) …O(1) . Preliminary bioassay indicated that the title compound possessed antiviral activity to some extent.     

Synthesis and Crystal Structure of （3R,4R）-5-（2,4-Dichlorobenzoyl）-4-（4-nitrophenyl）-6-（phenylamino）-3,4-dihydro-2H-thiopyran-3-carbonitrile

The title compound(C25H16Cl2N3O3S),as a thiopyran derivative,has been synthe-sized by the cyclization of an organic intermediate obtained from Baylis-Hillman adducts with a β-aroylthioamide using copper(I) salt as the catalyst.The crystal belongs to the monoclinic system,space group P21/c with a = 13.668(3),b = 8.4803(17) c = 21.999(4) ,β = 113.57(3)°,V = 2337.2(10) 3,Z = 4,Mr = 510.38,Dc = 1.451 g/cm3,μ = 0.401 mm-1,F(000) = 1048,the final R = 0.0487 and wR = 0.1079 for 3678 observed reflections with I > 2σ(I).     

Hydrothermal Synthesis and Crystal Structure of a 1D Cu（II） Coordination Polymer： [Cu（bbpy）（H_2bptc）]_n Constructed by a Tetracarboxylic Acid

The title compound [Cu(bbpy)(H2bptc)]n (bbpy = 4,4'-dimethyl-2,2'-bipyridine and H4bptc = 1,1'-biphenyl-2,2?,3,3'-tetracarboxylic acid) has been synthesized by hydrothermal reaction, and its structure was determined by X-ray diffraction and characterized by elemental analysis, IR spectrum and thermogravimetric analysis. The crystal is of triclinic, space group P1 with a = 11.2831(12), b = 11.6718(13), c = 11.7771(13), α = 105.392(2), β = 108.382(2), γ = 112.397(2)o, CuC28H20N2O8, Mr = 576.00, V = 1222.4(2)3, Dc = 1.565 g/cm3, F(000) = 590, μ = 0.951 mm-1, S = 1.022 and Z = 2. The final refinement gave R = 0.0405 and wR = 0.1142 for 4270 observed reflections with I > 2σ(I). The title complex has a 1D [Cu(bbpy)(H2bptc)]n chain structure, in which the extensive hydrogen-bond interactions make the chain more stable. The neighboring parallel chains are further packed into a 2D layer structure via π···π stacking interaction between the pyridine rings of bbpy ligands. Moreover, the adjacent layers are interconnected by the C-H···π interactions to form a 3D metal-organic framework.     

Synthesis,Crystal Structure and Spectroscopic Properties of N,N′-Diphenyl-N,N′-bis(2-fluorophenyl)-1,1′-biphenyl-4,4′-diamine

A fluorinated tetraphenylbenzidine derivative, N,N′-diphenyl-N,N′-bis(2-fluorophenyl)-1,1′-biphenyl-4,4′-diamine (C36H26F2N2, Mr = 524.59) was synthesized via the palladiumcatalyzed Buchwald-Hartwig reaction of N,N′-diphenyl-1,1′-biphenyl-4,4′-diamine with 2-fluoroiodobenzene (yield: 75%) and structurally characterized. It crystallizes in monoclinic, space group P21/n with a = 9.820(7), b = 14.305(11), c = 10.233(8) , β = 108.973(9)o, V = 1359.3(18) 3, Z = 2, Dc = 1.282 g/cm3, μ(MoKα) = 0.084 mm-1, F(000) = 548, S = 1.018, the final R = 0.0439 and wR = 0.0928. It presents a linear centrosymmetric framework constituted by a linkage of biphenyl as a bridge and two fluorinated diphenylamine moieties. The UV-Vis absorption and fluorescence spectra of the title compound were also investigated. This compound emits intense blue fluorescence with a peak wavelength of 406 nm in film.     

Synthesis,Crystal Structure and Electrochemical Property of the Ferrocenyl Schiff-base (E)-N’(Ferrocene Ethylidene)Picolino Hydrazide

A novel Schiff-base compound based on ferrocene C18H17OFeN3 (1) has been synthesized and characterized by X-ray diffraction. The title compound crystallizes in monoclinic, space group P21/c with a = 19.2343(17), b = 10.5084(9), c = 7.9373(7) , β = 97.7740°, Z = 4, V = 1589.6(2) 3, Dc = 1.451 g/cm3, μ(MoKα) = 0.956 mm-1, F(000) = 720, the final R = 0.0343 and wR = 0.0973 for 2759 observed reflections (I > 2σ(I)). Electrochemical measurements exhibit that compound 1 undergoes a reversible one-electron redox process.     

Synthesis and Characterization of （4R,5R）-1,3-dioxolance-4,5-bis（2-pyridineacrboxylic acid）

The title compound, (4R,5R)-1,3-dioxolance-4,5-bis(2-pyridineacrboxylic acid), has been synthesized and characterized by single-crystal X-ray diffraction, IR, NMR, and MS analyses. Crystal structure of the title compound was grown from ETOH by slow diffusion at room temperature. The title compound crystallizes in monoclinic, space group C2 with a = 17.805(3), b = 11.459(3), c = 11.1656(17) , β = 113.066(4)°, V = 2095.9(6) 3, Z = 4, F(000) = 880, Dc = 1.332 Mg/m-3, C23H20N2O6, Mr = 420.41 and μ = 0.10 mm-1